Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

All articles by Andrea S. Blevins Primeau, PhD, MBA

This fact sheet evaluates the data that suggest that aspirin can reduce the risk of liver and ovaria

Medicine

Common Cardiovascular Drugs Associated With Reduced Lung Cancer Mortality

Andrea S. Blevins Primeau, PhD, MBA

September 25, 2020

Aspirin, metformin, and statins were independently associated with decreased lung cancer mortality, according to a population-based study.

Medicine

ASCO Releases Position Statement on Home Infusion of Anticancer Treatments

Andrea S. Blevins Primeau, PhD, MBA

August 17, 2020

ASCO raises concerns about the home infusion of anticancer therapies including patient and caregiver safety, adequate oncology infusion nurses, and reimbursement issues.

Medicine

Lung Cancer Trials Supported by the Pharmaceutical Industry More Likely to Report Strong Evidence, Be Open Access

Andrea S. Blevins Primeau, PhD, MBA

July 30, 2020

A study of clinical trials found no evidence of bias in the reporting of clinical trials supported by pharmaceutical companies compared with studies that had other funding sources.

An FDA pilot program to promote transparency in clinical studies falls short of similar efforts by its European and Canadian counterparts.

Medicine

The Effect of the COVID-19 Pandemic on Telehealth

Andrea S. Blevins Primeau, PhD, MBA

July 24, 2020

Regulations on telehealth services were rapidly deregulated early into the COVID-19 pandemic, but questions remain about quality of care and patient disparities.